FDA now ‘concerned’ about BPA
The Food and Drug Administration has said for the first time it has “some concern about the potential effects of BPA [bisphenol A] on the brain, behavior and prostate gland,” particularly on fetuses, infants and children, though it’s stopped short of taking regulatory action. The FDA was expected to announce a decision about BPA’s safety before the end of 2009, but it missed the deadline.
BPA is a hormone-mimicking chemical present in more than 90 percent of Americans and often used in the linings of cans and No. 7 plastics. In a recent news conference, the FDA announced it is continuing to research the chemical with targeted studies.
The Washington Post quoted one anonymous Obama administration official involved in talks between the White House and FDA as saying, “They have new evidence that makes them worried, but they don’t have enough proof to justify pulling the stuff, so what do you do? You warn the people, but you don’t want to create panic.”